MedPath
NMPA Approval

Paracetamol Oral Solution

国药准字H36022224

March 18, 2021

Drug Information

对乙酰氨基酚口服溶液

口服溶液剂

2.4%

化学药品

March 18, 2021

Company Information

Applicant Company

Manufacturing Company

江西省铜鼓县迎宾大道168号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

对乙酰氨基酚口服溶液 - NMPA 批准文号 | MedPath